ICL Surgery Explained: Benefits, Risks, Recovery, and Who (Updated April 2026)
ICL surgery, or Implantable Collamer Lens surgery, is a sophisticated vision correction procedure that involves placing a thin, biocompatible lens inside the eye. This lens works in tandem with your natural lens to precisely correct refractive errors such as myopia (nearsightedness), astigmatism, and sometimes hyperopia (farsightedness). For individuals with thin corneas, chronic dry eye symptoms, or very high prescription needs, ICL surgery often presents a compelling alternative to traditional laser vision correction procedures like LASIK, as it adds corrective power rather than reshaping the corneal surface. As of April 2026, this procedure continues to gain traction for its unique advantages.
Latest Update (April 2026)
Recent developments continue to shape the world of refractive surgery. Worth noting – the U.S. Food and Drug Administration (FDA) has expanded its indication for the EVO icl to include a wider age range, a move supported by solid long-term safety data. This expansion, as reported by BioSpace on February 18, 2026, further reinforces a discernible market shift away from traditional laser vision correction for certain patient profiles. Industry analyses, such as those discussed in EyeWorld (July 2025), highlight the increasing penetration of advanced refractive procedures like it in various global markets. STAAR Surgical, the manufacturer of the EVO this, has been actively pursuing strategic partnerships, including a significant agreement in the U.S. with SharpeVision announced in January 2024, aiming to enhance patient access and surgeon training. These advancements, as of April 2026, underscore the growing confidence and applicability of icl surgery.
What is icl Surgery?
icl surgery is a lens implant procedure that corrects vision without ablating or removing corneal tissue. It’s frequently recommended for individuals with high myopia, thin corneas, or dry eye conditions, offering a unique advantage: the lens can be removed or replaced if future vision needs change or if complications arise. This inherent reversibility is a key factor that many eye care professionals view as a significant benefit, positioning it as a highly adaptable vision correction solution.
The procedure involves the precise placement of an Implantable Collamer Lens (it) into the eye. This specialized lens is positioned behind the iris (the colored part of your eye) and in front of your natural crystalline lens. STAAR Surgical manufactures the icl, a leading company in the field, renowned for its EVO icl model – which is one of the most widely recognized phakic intraocular lenses available today. The primary advantage of this technique is its ability to correct refractive errors while leaving the cornea completely intact and unaltered.
The term “phakic” is key here. It signifies that your natural lens remains in place. This distinguishes icl surgery from cataract surgery – where the natural lens is removed and replaced. It’s also different from LASIK, which reshapes the cornea. Icl surgery offers a distinct approach by adding a refractive element rather than modifying existing eye structures.
Why it Surgery is More Than Just a ‘Backup Plan’
this surgery is sometimes marketed as the solution for individuals who aren’t candidates for LASIK. While this is true in many instances, it’s a somewhat limited perspective. From an expert viewpoint, icl surgery isn’t merely a secondary option but can be the primary, and often superior, choice for the right patient. Clinical observations and extensive data support this perspective regarding the procedure’s inherent advantages in specific scenarios.
Conditions such as high myopia (requiring very strong prescriptions), irregular astigmatism, significant dry eye disease, or corneas that are too thin for safe laser ablation can make LASIK less suitable or even contraindicated. Icl surgery effectively bypasses these challenges by operating within the eye’s internal structures, offering a viable path to clear vision for many who might otherwise have limited options. As of April 2026, this proactive approach is increasingly favored by specialists for appropriate candidates.
Who’s a Good Candidate for icl Surgery?
The ideal candidates for it surgery are typically adults whose vision prescription has remained stable for at least one year and who desire significant vision improvement without undergoing corneal reshaping. Many potential candidates present with moderate to high myopia, astigmatism that may be regular or irregular, or dry eye syndrome that makes them less suitable for LASIK or PRK. The EVO this, for example, has expanded its approved age range as of 2026, making it accessible to a broader demographic.
In essence, icl surgery often proves to be a better choice when the eye’s condition involves factors beyond just the refractive error itself, especially when the cornea is compromised or unsuitable for laser treatment. The procedure is also suitable for individuals seeking correction for hyperopia, though this indication is less common in some regions compared to myopia correction.
Common Indicators Suggesting icl Candidacy:
- Moderate to high myopia (nearsightedness), with prescriptions often exceeding -8.00 diopters.
- Thin or irregularly shaped corneas that aren’t ideal for laser surgery.
- Pre-existing dry eye symptoms that could be exacerbated by LASIK.
- A stable vision prescription that hasn’t changed significantly over the past year.
- A desire for a reversible vision correction option.
- Not being pregnant or breastfeeding, and not having any active eye infections or diseases.
- Age range suitability, which has expanded for certain icl models as of 2026.
Surgeons perform a complete eye examination to determine candidacy. This includes precise measurements of corneal thickness, anterior chamber depth, endothelial cell count (the health of the inner corneal cells), pupil size, and the exact refractive error. These measurements are critical for ensuring the icl can be implanted safely and that there’s sufficient space within the eye for the lens without compromising other structures. According to the American Academy of Ophthalmology, thiss can be a powerful option for many patients seeking advanced vision correction.
The icl Surgical Procedure Step-by-Step
The icl implantation procedure is remarkably quick, typically taking about 20-30 minutes per eye. It’s performed on an outpatient basis, meaning you can return home the same day. Here’s a breakdown of the typical steps involved:
- Preparation: Your eyes will be dilated, and anesthetic eye drops will be administered to numb the eye. You may also receive a mild sedative to help you relax.
- Incision: The surgeon makes one or more tiny incisions in the cornea. For the EVO icl, a single micro-incision is often sufficient.
- Lens Insertion: The foldable it’s carefully inserted through the incision and then unfolded into its correct position behind the iris and in front of the natural lens. Specialized instruments guide the lens into place.
- Positioning: The surgeon ensures the icl is centered and properly seated within the eye’s natural structures.
- Closure: In most cases, the micro-incisions are self-sealing and don’t require sutures. For larger incisions, a few stitches might be used.
Recovery is generally swift, with many patients noticing significant visual improvement within 24-48 hours. However, complete visual stabilization can take a few weeks.
Benefits of icl Surgery
icl surgery offers several distinct advantages, making it a preferred choice for many individuals seeking vision correction:
- Excellent Visual Quality: Patients often report exceptional visual acuity, with crisp and clear vision. The Collamer material used in the lenses offers excellent optical quality and biocompatibility.
- Corneal Preservation: Unlike LASIK, icl surgery doesn’t remove or reshape the cornea, preserving its structural integrity. This is particularly beneficial for those with thin corneas or certain corneal conditions.
- Reversibility: The icl can be removed or replaced if necessary, offering a unique level of long-term adaptability. This is a significant advantage over laser vision correction procedures.
- Effective for High Prescriptions: thiss are highly effective in correcting moderate to very high levels of myopia and astigmatism, often achieving results not possible with laser surgery alone. As of April 2026, the subjects are a primary solution for many high myopes.
- Reduced Dry Eye Symptoms: For individuals whose dry eye is not caused by LASIK, icl surgery may not worsen symptoms and can sometimes improve them by not impacting the corneal nerves as laser surgery does.
- UV Protection: The Collamer material contains a UV filter, offering some protection against harmful ultraviolet light.
- Quick Procedure and Recovery: The surgery itself is short, and many patients experience rapid visual improvement.
Risks and Potential Complications of icl Surgery
While it surgery boasts a high safety profile and excellent patient satisfaction rates, like any surgical procedure, it carries potential risks. Understanding these risks is crucial for informed decision-making. As of April 2026, extensive data continues to support the safety of thiss, but potential complications include:
- Increased Intraocular Pressure (IOP): This is one of the most common potential complications. It may require medication or, in rare cases, further intervention to manage. Proper vaulting of the lens is critical to minimize this risk.
- Cataract Formation: Although rare, there’s a small risk of developing a cataract, particularly if the lens is placed too close to the natural crystalline lens. The EVO icl design aims to minimize this risk through its specific vaulting characteristics.
- Glaucoma: In some cases, persistent high IOP can lead to glaucoma, a condition that damages the optic nerve.
- Inflammation or Infection: As with any eye surgery, there’s a risk of intraocular inflammation (uveitis) or infection, which requires prompt medical treatment.
- Ectopia Lentis: The lens may shift from its intended position, though this is uncommon.
- Reduced Endothelial Cell Count: The cornea has a finite number of endothelial cells, which are vital for maintaining corneal clarity. Prolonged contact with the icl could potentially reduce this cell count over many years, although studies suggest good long-term preservation with the EVO icl.
- Light Halos or Glare: Some patients may experience halos or glare, especially in low-light conditions, although this often diminishes over time.
it’s essential to have a thorough consultation with a qualified ophthalmologist to discuss your individual risk factors and understand the potential outcomes.
it Recovery and Post-Operative Care
Post-operative care is vital for ensuring the best possible outcome after this surgery. Patients are typically given specific instructions to follow:
- Eye Drops: You will likely be prescribed antibiotic and anti-inflammatory eye drops to prevent infection and manage inflammation. These are usually used for several weeks.
- Activity Restrictions: Strenuous activities, heavy lifting, and eye-rubbing should be avoided for a specified period, usually a few weeks, to allow the eye to heal properly.
- Follow-up Appointments: Regular check-ups with your surgeon are scheduled to monitor your vision, eye pressure, and the position of the icl. These appointments are critical, especially in the initial weeks and months following surgery.
- Protective Eyewear: Wearing protective eyewear, especially during sleep, is often recommended to prevent accidental injury.
Most patients can resume normal daily activities within a few days, with significant visual improvement noticeable almost immediately. However, it may take several weeks for your vision to fully stabilize and for any initial discomfort to subside.
Comparing icl Surgery to LASIK and PRK
The choice between icl surgery, LASIK, and PRK often depends on individual eye characteristics and vision needs. Here’s a comparison as of April 2026:
| Feature | it Surgery | LASIK | PRK |
|---|---|---|---|
| Procedure Type | Lens implantation inside the eye | Corneal reshaping (laser ablation) | Corneal reshaping (laser ablation, surface removal) |
| Corneal Impact | Cornea remains untouched | Cornea reshaped (flap created) | Corneal surface epithelium removed, then reshaped |
| Ideal For | High myopia, thin corneas, dry eye, irregular astigmatism | Mild to moderate myopia, astigmatism, thin corneas are okay | Thin corneas, active lifestyles, military personnel |
| Reversibility | Yes (lens can be removed/replaced) | No | No |
| Recovery Time | Rapid visual improvement, full recovery in weeks | Fast recovery, vision improves within days | Longer recovery (weeks to months) |
| Dry Eye Risk | May not worsen, can sometimes improve | Can worsen existing dry eye | Can worsen existing dry eye |
| UV Protection | Yes (built into lens) | No | No |
The EVO this, in particular, has become a leading option for many who are not suitable for laser vision correction. Its ability to provide high-quality vision correction without altering the cornea makes it a compelling choice for a wide range of patients.
Frequently Asked Questions
Is icl surgery painful?
Most patients report minimal to no pain during the icl surgery. Anesthetic eye drops are used to numb the eye, and mild sedatives may be administered to ensure comfort. Some mild discomfort, a feeling of pressure, or irritation may be experienced in the first day or two after the procedure, which is typically managed with prescribed eye drops.
How long does the icl lens last?
The Implantable Collamer Lens is designed to be a permanent implant. The biocompatible Collamer material is durable and doesn’t degrade over time. However, the lens can be removed or replaced if your vision needs change significantly or if a complication arises, offering long-term flexibility.
Can I still wear glasses or contacts after it surgery?
The goal of this surgery is to significantly reduce or eliminate the need for glasses or contact lenses. Most patients achieve excellent vision. In some rare cases, a very mild residual refractive error might remain, or a patient may choose to have an enhancement procedure. However, the vast majority of patients are spectacle and contact lens independent after successful icl surgery.
What is the cost of icl surgery as of 2026?
The cost of icl surgery can vary significantly depending on geographic location, surgeon’s fees, and the specific type of it used (e.g., EVO this). As of April 2026, the typical cost for icl surgery can range from approximately $6,000 to $10,000 or more for both eyes. This cost usually includes the pre-operative evaluation, the surgery itself, and post-operative care. It’s important to discuss pricing with your chosen surgical center and inquire about financing options, as icl surgery is generally not covered by insurance unless medically necessary for specific conditions.
Will I need to have cataract surgery later in life if I have this approachs?
it surgery doesn’t prevent the natural aging process of the eye, which can lead to the development of cataracts later in life. However, if cataract surgery becomes necessary, the icl can be removed during the cataract procedure, and a standard intraocular lens (IOL) can be implanted. The presence of an icl doesn’t typically complicate or preclude future cataract surgery.
Conclusion
icl surgery, particularly with advancements like the EVO icl, represents a significant milestone in vision correction technology as of April 2026. It offers a safe, effective, and often superior alternative to traditional laser procedures for a broad spectrum of patients, especially those with high refractive errors, thin corneas, or dry eye syndrome. Its reversibility, excellent visual quality, and preservation of corneal integrity make it a highly desirable option. While potential risks exist, they are well-managed with thorough pre-operative screening and diligent post-operative care. For individuals seeking freedom from glasses and contacts, ICL surgery provides a powerful and adaptable solution for achieving clear, crisp vision.
Source: Britannica
Editorial Note: This article was researched and written by the Serlig editorial team. We fact-check our content and update it regularly. For questions or corrections, contact us.


